Form 8-K - Current report:
SEC Accession No. 0001185185-25-001713
Filing Date
2025-11-14
Accepted
2025-11-14 10:03:03
Documents
14
Period of Report
2025-11-13
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igc8k111425.htm   iXBRL 8-K 29731
2 EXHIBIT 99.1 igcex99-1.htm EX-99.1 68794
3 GRAPHIC image_001.jpg GRAPHIC 5199
  Complete submission text file 0001185185-25-001713.txt   284320

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE igc-20251113.xsd EX-101.SCH 3010
5 XBRL LABEL FILE igc-20251113_lab.xml EX-101.LAB 34235
6 XBRL PRESENTATION FILE igc-20251113_pre.xml EX-101.PRE 22355
16 EXTRACTED XBRL INSTANCE DOCUMENT igc8k111425_htm.xml XML 3542
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 251482100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)